Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Thyroid Gland Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
5 drugs · 9 active trials
5 drugs · 3 active trials
10 drugs · 42 active trials
Outside the funnel: Phase not stated 1. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 19 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Claturafenib | Phase 1 | Phase 1 | 2 | 0 | 0 | 2 | 0 | — | — | Jul 5, 2022 |
| Fluorouracil | Phase 1 | Phase 1 | 1 | 0 | 0 | 1 | 0 | — | — | Jul 5, 2022 |
| Lapatinib | Phase 1 | Phase 1 | 1 | 0 | 0 | 1 | 0 | — | — | Sep 27, 2013 |
| Leucovorin | Phase 1 | Phase 1 | 1 | 0 | 0 | 1 | 0 | — | — | Jul 5, 2022 |
| Oxaliplatin | Phase 1 | Phase 1 | 1 | 0 | 0 | 1 | 0 | — | — | Jul 5, 2022 |
| Temsirolimus | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 2010-06 |
| Azacitidine | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Oct 27, 2014 |
| Bexarotene | Phase 1 | Early Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2008-11 |
| Cixutumumab | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2010-10 |
| Erlotinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2006-12 |
| Etoposide | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Aug 31, 2018 |
| Temozolomide | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2017-12 |
| Valproic Acid | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Oct 16, 2012 |
| Vatalanib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2004-12 |
| Veliparib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2017-12 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.